Literature DB >> 15930385

The generation of a 17 kDa neurotoxic fragment: an alternative mechanism by which tau mediates beta-amyloid-induced neurodegeneration.

So-Young Park1, Adriana Ferreira.   

Abstract

Recently, we have shown that the microtubule-associated protein tau is essential for beta-amyloid (Abeta)-induced neurotoxicity in hippocampal neurons. However, the mechanisms by which tau mediates Abeta-induced neurite degeneration remain poorly understood. In the present study, we analyzed whether tau cleavage played a role in these events. Our results showed that pre-aggregated Abeta induced the generation of a 17 kDa tau fragment in cultured hippocampal neurons. The generation of this fragment was preceded by the activation of calpain-1. Conversely, inhibitors of this protease, but not of caspases, completely prevented tau proteolysis leading to the generation of the 17 kDa fragment and significantly reduced Abeta-induced neuronal death. Furthermore, the expression of this fragment in cultured hippocampal neurons induced the formation of numerous varicosity-bearing tortuous processes, as well as the complete degeneration of some of those neurite processes. These results suggest that Abeta-induced neurotoxicity may be mediated, at least in part, through the calpain-mediated generation of a toxic 17 kDa tau fragment. Collectively, these results provide insight into a novel mechanism by which tau could mediate Abeta-induced neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15930385      PMCID: PMC1352316          DOI: 10.1523/JNEUROSCI.1125-05.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  61 in total

1.  Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology.

Authors:  J H Su; M Zhao; A J Anderson; A Srinivasan; C W Cotman
Journal:  Brain Res       Date:  2001-04-20       Impact factor: 3.252

2.  Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease.

Authors:  C X Gong; T Lidsky; J Wegiel; L Zuck; I Grundke-Iqbal; K Iqbal
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

3.  The neuronal microtubule-associated protein tau is a substrate for caspase-3 and an effector of apoptosis.

Authors:  L Fasulo; G Ugolini; M Visintin; A Bradbury; C Brancolini; V Verzillo; M Novak; A Cattaneo
Journal:  J Neurochem       Date:  2000-08       Impact factor: 5.372

4.  Neurotoxicity induces cleavage of p35 to p25 by calpain.

Authors:  M S Lee; Y T Kwon; M Li; J Peng; R M Friedlander; L H Tsai
Journal:  Nature       Date:  2000-05-18       Impact factor: 49.962

5.  mu-Calpain activation, DNA fragmentation, and synergistic effects of caspase and calpain inhibitors in protecting hippocampal neurons from ischemic damage.

Authors:  A Rami; R Agarwal; G Botez; J Winckler
Journal:  Brain Res       Date:  2000-06-02       Impact factor: 3.252

6.  Microtubule formation and neurite growth in cerebellar macroneurons which develop in vitro: evidence for the involvement of the microtubule-associated proteins, MAP-1a, HMW-MAP2 and Tau.

Authors:  A Ferreira; J Busciglio; A Cáceres
Journal:  Brain Res Dev Brain Res       Date:  1989-10-01

7.  PD98059 prevents neurite degeneration induced by fibrillar beta-amyloid in mature hippocampal neurons.

Authors:  M Rapoport; A Ferreira
Journal:  J Neurochem       Date:  2000-01       Impact factor: 5.372

8.  Proapoptotic effects of tau cleavage product generated by caspase-3.

Authors:  C W Chung; Y H Song; I K Kim; W J Yoon; B R Ryu; D G Jo; H N Woo; Y K Kwon; H H Kim; B J Gwag; I H Mook-Jung; Y K Jung
Journal:  Neurobiol Dis       Date:  2001-02       Impact factor: 5.996

9.  Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease.

Authors:  T T Rohn; E Head; J H Su; A J Anderson; B A Bahr; C W Cotman; D H Cribbs
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

10.  Beta-amyloid-induced activation of caspase-3 in primary cultures of rat neurons.

Authors:  N Marín; B Romero; F Bosch-Morell; M Llansola; V Felipo; J Romá; F J Romero
Journal:  Mech Ageing Dev       Date:  2000-10-20       Impact factor: 5.432

View more
  120 in total

1.  Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer's disease.

Authors:  Sophie Sokolow; Kristen M Henkins; Tina Bilousova; Bianca Gonzalez; Harry V Vinters; Carol A Miller; Lindsey Cornwell; Wayne W Poon; Karen H Gylys
Journal:  J Neurochem       Date:  2015-01-13       Impact factor: 5.372

2.  β-Amyloid carrying the Dutch mutation has diverse effects on calpain-mediated toxicity in hippocampal neurons.

Authors:  Alexandra M Nicholson; Lindsey A Wold; Dominic M Walsh; Adriana Ferreira
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

3.  Tyrosine nitration within the proline-rich region of Tau in Alzheimer's disease.

Authors:  Juan F Reyes; Yifan Fu; Laurel Vana; Nicholas M Kanaan; Lester I Binder
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

4.  Membrane cholesterol modulates {beta}-amyloid-dependent tau cleavage by inducing changes in the membrane content and localization of N-methyl-D-aspartic acid receptors.

Authors:  Alexandra M Nicholson; D Nicole Riherd Methner; Adriana Ferreira
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

Review 5.  Cellular factors modulating the mechanism of tau protein aggregation.

Authors:  Sarah N Fontaine; Jonathan J Sabbagh; Jeremy Baker; Carlos R Martinez-Licha; April Darling; Chad A Dickey
Journal:  Cell Mol Life Sci       Date:  2015-02-11       Impact factor: 9.261

Review 6.  It's all about tau.

Authors:  Cheril Tapia-Rojas; Fabian Cabezas-Opazo; Carol A Deaton; Erick H Vergara; Gail V W Johnson; Rodrigo A Quintanilla
Journal:  Prog Neurobiol       Date:  2018-12-31       Impact factor: 11.685

7.  Multiple mechanisms of extracellular tau spreading in a non-transgenic tauopathy model.

Authors:  Meghan N Le; Wonhee Kim; Sangmook Lee; Ann C McKee; Garth F Hall
Journal:  Am J Neurodegener Dis       Date:  2012-11-25

Review 8.  Therapeutic strategies for the treatment of tauopathies: Hopes and challenges.

Authors:  Mansi R Khanna; Jane Kovalevich; Virginia M-Y Lee; John Q Trojanowski; Kurt R Brunden
Journal:  Alzheimers Dement       Date:  2016-10       Impact factor: 21.566

9.  Hyperglycemia-induced tau cleavage in vitro and in vivo: a possible link between diabetes and Alzheimer's disease.

Authors:  Bhumsoo Kim; Carey Backus; Sangsu Oh; Eva L Feldman
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

10.  Oligomerization of the microtubule-associated protein tau is mediated by its N-terminal sequences: implications for normal and pathological tau action.

Authors:  H Eric Feinstein; Sarah J Benbow; Nichole E LaPointe; Nirav Patel; Srinivasan Ramachandran; Thanh D Do; Michelle R Gaylord; Noelle E Huskey; Nicolette Dressler; Megan Korff; Brady Quon; Kristi Lazar Cantrell; Michael T Bowers; Ratnesh Lal; Stuart C Feinstein
Journal:  J Neurochem       Date:  2016-04-20       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.